Back to Browse Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 7

Relationship between frequency, length, and treatment outcome of exacerbations to baseline lung function and lung density in alpha-1 antitrypsin-deficient COPD

Authors Vijayasaratha K, Stockley RA

Received 14 March 2012

Accepted for publication 17 October 2012

Published 27 November 2012 Volume 2012:7 Pages 789—796

DOI http://dx.doi.org/10.2147/COPD.S31797

Review by Single-blind

Peer reviewer comments 3

Kesavaperumal Vijayasaratha,1 Robert A Stockley2

1Lung Investigation Unit, 2Research and Development, University Hospital Birmingham NHS Trust, Birmingham, UK

Background: Diary cards are useful for analyzing exacerbations in chronic obstructive pulmonary disease (COPD), although factors influencing the length and frequency of each episode are poorly understood. This study investigated factors that influence the features of exacerbations in patients with alpha-1 antitrypsin (AAT) deficiency (PiZ phenotype) and COPD.
Methods: Daily diary cards were collected over 2 years. Patients had emphysema visualized and quantified by computed tomography scan, and had at least one documented exacerbation in the previous year.
Results: The patients (n = 23) had a mean age of 52.5 years, forced expiratory volume in one second (FEV1) of 1.2 L (38.4% predicted), corrected gas transfer (KCO) of 0.90 mmol/min/kPa/L (59.7% predicted), and 15th percentile lung density of 44.55 g/L. Two hundred and sixty-three exacerbations (164 treated) were identified. The frequency of treated exacerbations correlated negatively with KCO% predicted (r = −0.432; P = 0.022). Exacerbation length (determined for 17 of the patients for whom diary card data through the episode were available) correlated negatively with baseline 15th percentile lung density (r = −0.361; P = 0.003), and increased the longer treatment was delayed (r = 0.503; P < 0.001). Treatment delay was shorter with higher day 1 symptom score, lower baseline FEV1, FEV1/forced vital capacity, and lower 15th percentile lung density (r = −0.368, 0.272, 0.461, and 0.786; P = 0.004, 0.036, <0.001, and <0.001, respectively). Time to resolution of exacerbation after treatment initiation was not affected by treatment delay, but correlated negatively with KCO% predicted (r = −0.647; P = 0.007).
Conclusion: In alpha-1 antitrypsin deficiency, the frequency and length of resolution of exacerbation were related to baseline gas transfer. Treatment delay adversely affected exacerbation length, and lung density was the best independent predictor of delay in starting treatment.

Keywords: alpha-1 antitrypsin deficiency, antibiotic, exacerbation, gas transfer, lung density, lung function

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] View Full Text [HTML] 

 

Readers of this article also read:

Novel single-nucleotide polymorphisms in the calsequestrin-1 gene are associated with Graves’ ophthalmopathy and Hashimoto’s thyroiditis

Lahooti H, Cultrone D, Edirimanne S, Walsh JP, Delbridge L, Cregan P, Champion B, Wall JR

Clinical Ophthalmology 2015, 9:1731-1740

Published Date: 18 September 2015

Lobe-based computed tomography assessment of airway diameter, airway or vessel number, and emphysema extent in relation to the clinical outcomes of COPD

Kurashima K, Takaku Y, Hoshi T, Kanauchi T, Nakamoto K, Takayanagi N, Yanagisawa T, Sugita Y, Kawabata Y

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:1027-1033

Published Date: 2 June 2015

Reduction of exacerbation frequency in patients with COPD after participation in a comprehensive pulmonary rehabilitation program

van Ranst D, Stoop WA, Meijer JW, Otten HJ, van de Port IG

International Journal of Chronic Obstructive Pulmonary Disease 2014, 9:1059-1067

Published Date: 3 October 2014

Quantitative assessment of walking time and postural change in patients with COPD using a new triaxial accelerometer system

Kawagoshi A, Kiyokawa N, Sugawara K, Takahashi H, Sakata S, Miura S, Sawamura S, Satake M, Shioya T

International Journal of Chronic Obstructive Pulmonary Disease 2013, 8:397-404

Published Date: 2 September 2013

Frequency of heterozygous TET2 deletions in myeloproliferative neoplasms

Joseph Tripodi, Ronald Hoffman, Vesna Najfeld, et al

Cancer Management and Research 2010, 2:219-223

Published Date: 17 September 2010